Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination

International Journal of Clinical Oncology

Volumn 20, Issue 3, 2015, Pages 549-555

  Morimoto, Akiko ^a,b   Ueda, Yutaka ^a,b   Egawa Takata, Tomomi ^a,b   Yagi, Asami ^b   Terai, Yoshito ^a,c   Ohmichi, Masahide ^a,c   Ichimura, Tomoyuki ^a,d   Sumi, Toshiyuki ^a,d   Murata, Hiromi ^a,e   Kanzaki, Hideharu ^a,e   Nakai, Hidekatsu ^a,f   Mandai, Masaki ^a,f   Yoshino, Kiyoshi ^a,b   Fujita, Masami ^a,b   Kimura, Tadashi ^a,b   Saito, Junko ^a,g   Sobue, Tomotaka ^b   Nishikawa, Nobumichi ^h   Sekine, Masayuki ^h   Enomoto, Takayuki ^a,h   Horikoshi, Yorihiko ^a   Takagi, Tetsu ^a   more..

^a The Obstetrical Gynecological Society of Osaka   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KANSAI MEDICAL UNIVERSITY   (Japan)

^f Kindai University   (Japan)

^g Saito Women s Clinic   (Japan)

^h NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Adverse events; Governmental suspension of vaccination; HPV vaccine; Japan; Media reports

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; CHILD; CLINICAL ARTICLE; CLINICAL RESEARCH; COMPLEX REGIONAL PAIN SYNDROME; FEMALE; GOVERNMENT; HUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; QUESTIONNAIRE; SCHOOL CHILD; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; VACCINATION; YOUNG ADULT; ATTITUDE TO HEALTH; COMPLICATION; HEALTH CARE PLANNING; JAPAN; MASS MEDIUM; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; UTERINE CERVICAL NEOPLASMS; UTILIZATION;

ADOLESCENT; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PLANNING GUIDELINES; HUMANS; JAPAN; MASS MEDIA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; SURVEYS AND QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84930574602     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0723-1     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
2. Japanese Ministry of Health, Labour and Welfare. Vital Statistics in Japan, tabulated by Center for Cancer Control and Information Services, National Cancer Center, Japan May 12, 2012. Available via DIALOG. http://ganjoho.jp/pro/statistics/en/table_download.html Accessed April 2014
3. Munoz N, Bosch FX, Castellsague X et al (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278–285
4. Smith JS, Lindsay L, Hoots B et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621–632
5. Li N, Franceschi S, Howell-Jones R et al (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927–935
6. Miura S, Matsumoto K, Oki A et al (2006) Do we need a different strategy for HPV screening and vaccination in East Asia? Int J Cancer 119:2713–2715
7. Jacobs MV, Walboomers JM, Snijders PJ et al (2000) Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87:221–227
8. Clifford GM, Gallus S, Herrero R et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998
9. Franceschi S, Herrero R, Clifford GM et al (2006) Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119:2677–2684
10. de Sanjose S, Quint WG, Alemany L et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056
11. Onuki M, Matsumoto K, Satoh T et al (2009) Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci 100:1312–1316
12. Gilmour S, Kanda M, Kusumi E et al (2013) HPV vaccination programme in Japan. Lancet 382:768
13. The Global Advisory Committee on Vaccine Safety (GACVS). GACVS Safety update on HPV vaccines. 13 June 2013. Available via DIALOG. http://www.who.int/vaccine_safety/committee/topics/hpv/130619HPV_VaccineGACVSstatement.pdf Accessed April 2014
14. The Internaional Federation of Gynecology and Obstetrics (FIGO). FIGO statement on HPV vaccination safety. 2 Aug 2013. Available via DIALOG. http://www.figo.org/files/figo-corp/Statement%20on%20Safety%20of%20HPV%20vaccination%20-%20FINAL%20-%20AUGUST%202013.pdf Accessed April 2014
15. Darden PM, Thompson DM, Roberts JR et al (2013) Reasons for not vaccinating adolescents: national immunization survey of teens, 2008–2010. Pediatrics 131:645–651
16. Wong MC, Lee A, Ngai KL et al (2013) Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong. PLoS One 8:e71827
17. Sotiriadis A, Dagklis T, Siamanta V et al (2012) Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine. Arch Gynecol Obstet 285:1719–1724
18. Bodemer N, Muller SM, Okan Y et al (2012) Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine. Vaccine 30:3747–3756
19. Holman DM, Benard V, Roland KB et al (2014) Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168:76–82
20. Kessels SJ, Marshall HS, Watson M et al (2012) Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 30:3546–3556
21. Hanley SJ, Yoshioka E, Ito Y et al (2012) Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls. Vaccine 30:5740–5747
22. Dinh TA, Rosenthal SL, Doan ED et al (2007) Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health 40:559–563
23. Dempsey AF, Abraham LM, Dalton V et al (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19:531–538
24. Japanese Ministry of Health, Labour and Welfare. Healthcare Services where HPV vaccines are inoculated. Available via DIALOG. http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000038483.pdf Accessed April 2014
25. Daley MF, Crane LA, Markowitz LE et al (2010) Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 126:425–433
26. Chow SN, Soon R, Park JS et al (2010) Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine 28:3809–3817
27. American Academy of Pediatrics. Pediatricians can lay out evidence to allay fears over HPV vaccine. Available via DIALOG. http://aapnews.aappublications.org/content/early/2014/02/12/aapnews.20140212-1 Accessed May 2014